© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Albendazole didn’t come out of nowhere—its story runs through decades of effort to keep humans and animals healthier. Doctors and veterinarians have fought parasitic worms for a long time, and their struggles pushed chemists to explore benzimidazole derivatives. Albendazole’s discovery in the 1970s meant a real change, since it worked against a wide spectrum of worms. Researchers soon noticed something interesting: once inside the body, albendazole turns into albendazole sulfoxide, which actually tackles the parasites. So, albendazole sulfoxide became the star player doctors count on.
Albendazole sulfoxide doesn’t just have a long name. It stands out for dissolving in certain solvents better than albendazole and slips easily through biological barriers, including the blood-brain barrier. Chemists know it by several labels—Ricobendazole being a familiar trade name—yet the compound underneath stays the same. It’s a white-to-off-white powder, and its chemical backbone packs a sulfoxide group, which lets it take part in reactions beyond what albendazole can do itself. That extra oxygen atom, hanging out beside the sulfur, means the body’s enzymes have already done half the work breaking it down, and parasites can’t hide as easily.
No two batches of albendazole sulfoxide turn out quite alike unless the process is controlled tightly. Pharmacopeias set purity standards, usually demanding a content over 98%. Formulations must take particle size into account, since that affects how the medicine spreads out and dissolves in the body. Labeling typically points out its use as a prescription-only drug for worm infections in both humans and livestock, with explicit health warnings for pregnant women. In my work with regulatory filings, oversight bodies such as the FDA and EMA require all impurities to be identified, even if they show up in trace amounts, so quality never falls through the cracks.
Labs can’t risk half measures in synthesis. Most firms prepare albendazole sulfoxide by gently oxidizing albendazole in a solvent using hydrogen peroxide or other mild oxidants. Process engineers put a premium on temperature and pH control. The danger lies in over-oxidizing—turning the compound into albendazole sulfone, which doesn’t offer the same worm-fighting punch. Solvent choice matters not just for yield, but also for cutting down on hazardous waste. Scale matters, too: Producing grams for research takes less muscle than cranking out kilograms for animal health programs.
Once chemists have the sulfoxide in their hands, they sometimes modify side chains or tweak the central ring system to push activity higher or dodge resistance. Some groups react it with acids to craft salts that dissolve more readily, or tuck it into nanoparticles for targeted delivery. Modified versions could slow-release the drug, or deliver it to tough-to-reach organs. From working with medicinal chemists, I’ve seen firsthand how one functional group added here or there can mean hitting the same worms with less medicine—or avoiding common side effects in patients with already damaged livers.
People in research labs and clinics call albendazole sulfoxide by many names. Ricobendazole pops up often, though its IUPAC identity—methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate S-oxide—shows up on chemical registries. The abundance of synonyms can sometimes confuse suppliers or researchers chasing after new data. Without clear naming conventions, toxicology reports or pharmacokinetic studies can get muddled. Sticking to clear, global standards helps everyone stay on the same page, a lesson I learned the hard way sorting through published studies.
Albendazole sulfoxide may work wonders, but it carries quirks that make proper handling important. Its safety profile builds on decades of animal work; still, like many benzimidazoles, it can harm developing embryos or stress older animals’ livers. Technicians in pilot plants need gloves, masks, and dust control. Veterinary staff pay close attention to withdrawal periods before animals go to slaughter. Labeling reflects actual health risks, shaped by real-world poison control reports and farm audits. Approaching production with a safety mindset—not just ticking regulatory boxes—protects both staff and end-users.
Albendazole sulfoxide fights parasites in sheep, cattle, goats, and sometimes even in people, especially in places with heavy worm burdens. Its broad reach has a big impact in tropical regions, where losses from parasites can mean skipped meals or lost income. In cysticercosis or hydatid disease, reaching the brain or liver matters—and the drug’s ready absorption means fewer treatment failures. On mixed farms, effective dosing keeps both animals and people in better health. Policy makers and extension agents I’ve talked to describe how mass deworming, using reliable molecules like this one, transforms rural economies.
Labs keep poking at old boundaries. Researchers now measure drug resistance in parasites, tuning dosage schedules or combining albendazole sulfoxide with other molecules. Finding new formulations—maybe with higher solubility or longer shelf life—can stretch the reach of a single batch, which matters in places with limited cold storage. In the clinic, diagnostics grow more sensitive, so feedback from the field shapes how future drugs get developed. Working as a reviewer, I see proposals trying to use the molecule in cancer or immune disorders, where its old-school activity against microtubules opens new possibilities.
Toxicologists don’t take anything at face value. Albendazole sulfoxide can disrupt fetal development, so doctors heavily restrict its use in pregnant women and animals during gestation. At high doses or with prolonged use, livers show stress, and blood tests may reveal subtle anemia. Careful risk assessment comes from decades of pharmacovigilance, including field studies and case reports from rural clinics, not just big city hospitals. When data look shaky, regulators reduce permissible doses or pull products off the market outright. Balancing these facts with need remains a tightrope walk.
The world won’t stop needing solid anti-parasitics. Shifting climate patterns could move parasite hot spots, putting more pressure on current drugs. There’s a push for shorter treatment times, safer dosing, and new combinations that cut down on resistance. Researchers search out new delivery methods, such as slow-release implants, or modifications that cross stubborn tissue barriers. At the same time, environmental impact—especially drug residues in water supplies—draws more attention. The next wave of discovery comes from chemistry, animal health, and public health working together, not in silos. Those who champion open data and local engagement usually find the most practical solutions, informed both by hard evidence and the wisdom of front-line practitioners.
Albendazole sulfoxide stands out as a major player in tackling parasitic worms. Doctors reach for it when facing roundworm and tapeworm infections, things that remain a big worry in many parts of the world. These aren’t worries for only a few travelers or rare outbreaks. In my community work, I’ve seen firsthand how quickly intestinal parasites can sweep through families and even whole schools, especially where clean water or proper sanitation is lacking.
Albendazole sulfoxide is actually the form the human body makes after processing albendazole. This change matters. It’s this version that does the heavy lifting, upsetting the worms’ cell functions so they die off. Unlike older medicines, albendazole sulfoxide doesn’t just stun the parasites. It starves them of the fuel they need to survive.
According to the World Health Organization, parasitic worm infections affect hundreds of millions of people. Many of these folks are kids. Losing even a year to repeated infections can knock a student off track for life — not just in health, but in school, work, and even future income. I’ve lost count of families in low-income regions who depend on school-based deworming programs that hand out albendazole tablets. Without easy access to this treatment, the risks keep multiplying. Children face anemia, poor growth, and trouble concentrating.
Doctors don’t only turn to albendazole sulfoxide for gut-based infections. Cases like neurocysticercosis make a strong argument for its wider role. Neurocysticercosis, caused by pork tapeworms finding their way to the brain, can bring on seizures and even life-threatening swelling. For hospitals in places where this infection is common, albendazole sulfoxide counts as an essential medicine. Hydatid disease, another serious condition caused by dog tapeworms, also lands on the list. In both cases, tackling the infection involves weeks of treatment, and skipping doses may bring disastrous results.
Like any medicine, albendazole carries side effects—upset stomach, headaches, sometimes rash or temporary liver changes. The choice isn’t always easy. In tough cases, doctors monitor patients closely, balancing the need to clear the worms against possible complications. Emerging research points to a risk of drug resistance over time, a problem that can show up when communities keep using the same treatment year after year. This is something I’ve heard from health workers in parts of Africa and Asia, worried that mass deworming programs could lose their punch down the road.
Delivering reliable albendazole sulfoxide to those who need it takes a joint effort. Pharmaceutical quality controls, public health guidelines, and patient education all play a role. The medicine does its best work when people stick to the schedule and combine it with clean water, better hygiene, and good sanitation. National governments and global partners like UNICEF have stepped up to invest in regular drug donations and better diagnostics. Community health workers, often underpaid and overextended, keep the whole effort moving. Their focus on reaching out to both schools and remote villages keeps the treatment from missing the people who need it most.
Every family kept free of parasitic infections builds a stronger future for the entire community. Keeping albendazole sulfoxide within reach means fewer missed school days, healthier workers, and more secure lives. Ongoing research, stronger health systems, and thoughtful policies will determine how much further this medicine can go in making that difference.
Albendazole Sulfoxide does a solid job of clearing out parasitic worms, making it a common choice in hospitals and clinics. It’s valued in countries where soil-transmitted worms and tapeworms remain a problem. The impact of this medicine stretches beyond just treating infections — it helps kids grow better, keeps people at work, and lowers the spread of serious illnesses. But as with any medicine, the gains come with a few risks for side effects that anyone taking the drug ought to recognize.
Some folks notice effects that look a lot like a mild stomach bug. Common complaints include queasy stomach, stomach pain, and more frequent stools or diarrhea. Occasionally, people deal with headaches, dizziness, or a sore throat, especially after a dose on an empty stomach. Many people shake off these issues after a day or two, but stomach pain that sticks around deserves a mention to the doctor. For kids, diarrhea and vomiting can lead to dehydration pretty fast—in those cases, water and rest should not be ignored.
A handful of patients face bigger troubles, including signs that the liver doesn’t like the drug. Look for yellowed skin or eyes, dull pain in the right side under the ribs, or urine that turns unusually dark. Blood tests sometimes show drops in white cells or platelets, which leaves people open to infections or unusual bruising. Some rare cases involve fever, sore mouth, or easy bleeding. Anyone spotting these problems should call a nurse or doctor as soon as possible.
Like many medicines, Albendazole Sulfoxide sometimes sparks an allergy. Itchy skin, swelling of lips or face, hives, or trouble breathing point to a real emergency and need immediate medical help. Even if the reaction passes, every future dose deserves a closer look and, most times, a switch to a different treatment.
In places battling strong or chronic worm infections, patients sometimes use Albendazole Sulfoxide for weeks or longer. Regular use calls for regular blood and liver checks, especially for folks with pre-existing liver problems or anyone on other medicines processed through the liver. People with chronic illness, pregnant women, and breastfeeding mothers have to tread especially carefully: doctors often only recommend treatment if the reward outweighs the potential harm because there’s evidence Albendazole can cross into breastmilk and potentially reach developing infants.
Clear communication between patients and clinicians ensures the benefits shine without surprise setbacks. For many low-income regions, campaigns to treat whole communities count on the safety of these drugs. Side effects remain an important topic for patient education so people can speak up if things turn odd. The aim—whether you’re a health worker or someone whose family relies on Albendazole—lies in staying alert to problems and knowing when it’s time to ask for help. With smart use, these medicines keep working for the people who need them most.
Safer drugs and smart surveillance programs promise fewer surprises and better outcomes for everyone. No one wants a tough choice between treating an infection and risking a new health scare. Answering questions, sharing stories, and getting regular health checks go a long way in lowering those odds.
Dealing with parasite infections throws your body off. Doctors often recommend albendazole or its active form, albendazole sulfoxide. This medicine fights worms that can cause real trouble, from stomach pain to deeper problems with your organs. Many people hear about it after a stool test comes back positive or after a health check turns up something unexpected. Usually, these issues crop up during travel or after eating contaminated food. I’ve seen the anxiety first-hand—people worry about how to take the pill safely and how to avoid messing up their gut or making themselves sicker in the process.
Swallowing the right dose matters. Albendazole sulfoxide tablets work best with food—preferably meals that contain some fat. Fat helps your body absorb more of the medicine, getting it where it needs to go. Doctors typically suggest splitting the dose for tougher infections but might use a single dose for less serious cases. Younger kids or elderly folks often get smaller amounts, and pharmacists can show you how to crush the tablet if swallowing is tough. Never take more pills hoping for faster healing. Overdosing can harm your liver and upset your stomach for days. Drug stores label these medicines clearly for a reason, and pharmacists are happy to answer questions.
Before starting any antiparasitic medications, healthcare providers usually check your liver function with simple blood work. Albendazole sulfoxide pushes your liver, so anybody with a history of hepatitis or alcohol use needs extra care. Regular blood tests follow strong courses, tracking white blood cell counts because rare but serious drops can happen. People on other medications should mention everything, including herbal supplements, since mixing drugs can cause dangerous interactions. My neighbor learned this the hard way; mixing medicine for high blood pressure with albendazole landed him at the clinic with dizziness and nausea.
Itching, mild belly upset, and headache sometimes happen in the first day or two. These symptoms usually pass, but sudden rash, swelling, or trouble breathing signal allergic reactions that need emergency attention. Jaundice—the yellowing of skin or eyes—can point to serious liver trouble and shouldn’t be shrugged off. Parents sometimes worry about temporary hair loss. Medical literature shows this happens rarely, and hair usually grows back. Staying in touch with your healthcare provider keeps surprises at bay.
Taking medicine at the same time every day helps keep drug levels steady in the bloodstream. Skipping doses lets the parasites recover and could mean starting all over again. Washing hands and cooking food thoroughly keep parasites from coming back. After finishing a course, a follow-up stool test confirms the parasites are gone. Doctors often suggest bringing family members in for testing, too, since some infections spread easily among people living together. Keeping your follow-up dates and finishing your medicine even after symptoms improve lowers the risk of relapse. Health workers in busy clinics say that simple reminders—setting an alarm, writing down doses—help more than you’d think.
Decades of research support albendazole sulfoxide as a frontline choice for fighting many common intestinal worms. Cheap, widely available, and generally well tolerated, it still needs respect and careful use. Trust your prescriber, ask questions, and share any worries early. Quick action beats wishful waiting. I’ve seen too many people tough out symptoms, only to end up feeling worse. Listen to your body and stick with proven medical advice.
Albendazole sulfoxide handles some serious work in the world of medicine. Doctors rely on it to clear up tough infections like echinococcosis and neurocysticercosis. These aren’t common colds or run-of-the-mill bugs. I’ve seen patients struggling for years before a correct diagnosis brings this medication to the table. The drug goes after parasites that damage organs, sometimes even reaching the brain. That’s why a healthcare professional keeps a close eye on how and when it’s used.
In many countries, you won’t find albendazole sulfoxide on an open pharmacy shelf. Laws call for a prescription—one signed by a licensed provider. This limit exists for good reason. Not every tummy ache means a parasite is at fault, and the risks of misusing antiparasitic drugs go well beyond wasted money. If someone takes this drug when they shouldn’t, toxic side effects can follow. Liver reactions top the list of concerns, and regular blood work helps spot problems early.
Over the years, some folks have tried to cut corners. “My friend’s brother used this for worms,” they’ll say, reaching for pills online. The truth is, playing pharmacist can backfire quickly. The World Health Organization points to growing resistance in parasites because antiparasitics get used too much or the wrong way. Once resistance sets in, drugs stop working for everyone, not just the person taking a shortcut.
Albendazole sulfoxide also reacts with drugs like dexamethasone or praziquantel. Anyone who’s ever tried to unravel a long medication list knows errors happen easily. Without full medical records, one pill can undo the benefits of another—or spark serious side effects. For people with liver problems or on long-term medicine, the dangers multiply.
Regulations aren’t just red tape. They shape safety. In the United States, Europe, and many parts of Asia, the Food and Drug Administration or similar agencies demand prescriptions because they have tracked adverse outcomes from casual use. Even veterinarians need authorization before dosing animals. These checks protect the community and the healthcare workers who treat them.
Getting a prescription involves more than an office visit or a test result. Doctors check if treatment fits the person’s medical history, confirm the infection type, and plan rechecks to catch liver issues or allergic reactions. On top of that, they explain how to use the drug—on a full stomach, for a set number of days, not just until symptoms fade. Skipping steps can mean incomplete treatment and relapse.
Access to quality healthcare doesn’t reach everyone. Where doctors and labs remain out of reach, international health programs sometimes step in. Mass drug administration campaigns use albendazole in controlled, supervised settings to fight conditions like lymphatic filariasis. These efforts include health education and clear instructions. But outside those programs, getting the drug without a prescription puts individuals at risk.
Community pharmacies and clinics must watch for unsafe sales. Online stores make things trickier—counterfeit drugs flood the market, lacking both purity and tracking. Patients can protect themselves by asking for a prescription and choosing licensed pharmacies. This keeps care on a firm footing and shields everyone from shady products.
Every year, millions of women need parasite treatment. Albendazole stands out as a widely used medicine for worms. Its active form in the body, albendazole sulfoxide, does the real work against parasites. If you’re pregnant or breastfeeding, every pill demands a little more thinking. I’ve talked to family doctors and pharmacists who all say the same thing: risk to mother or baby always puts extra weight on decisions.
Researchers have studied albendazole in pregnant lab animals and seen some pretty clear trouble. High doses lead to harm, especially early in pregnancy. Birth defects and miscarriage risks seem to climb in animal tests. But labs are not the real world, and human data looks different. Case reports in people are sparse, but researchers have never seen major trouble show up at the doses used for treating worms in humans. Still, there just haven’t been large enough studies tracking pregnant women to know for sure.
Doctors lean on guidelines from groups like the World Health Organization and the Centers for Disease Control. Both recommend caution in the first trimester. The baby’s organs form during those weeks, and small risks matter more. If a woman discovers she is pregnant after taking a dose, she shouldn’t panic—one dose carries less risk than repeat exposures, and doctors rarely advise anything stronger than a regular checkup. If a woman has a worm infection later in pregnancy—especially if her health depends on getting treated—the benefits can outstrip the not-quite-certain risks.
Most drugs pass into breast milk in tiny amounts, and albendazole sulfoxide is no different. A few studies have measured the drug in breast milk and found only trace levels. That means a baby's likely to get a lot less of the drug from breastfeeding than the mother receives. Still, scientists don’t have the long-term data to promise total safety. The American Academy of Pediatrics once called albendazole “probably compatible” with nursing, and most doctors agree the risks look low if doses are spaced and if the baby’s growth and behavior remain normal.
In well-off countries, worm infections rarely threaten life and pregnancy care often takes priority. In regions with heavy parasite loads and undernutrition, untreated worms can put both mother and baby at risk. That shapes doctor’s choices. Organizations such as WHO have run mass deworming programs in places where the diseases carried by parasites risk stunting or killing babies before they’re ever born. In such cases, they recommend postponing treatment until after the first trimester and, if breastfeeding, treating only when clearly needed.
Pregnancy and nursing require open conversations with doctors and pharmacists. Every patient’s story is different—a malnourished woman in Ethiopia faces threats wealthier patients don’t. Still, safety comes first, and drug choice always includes a close look at the needed dose, infection risk, and timing. If albendazole seems needed, specialists can check local guidelines or even suggest waiting until after delivery if parasite burdens look low. I’ve seen pharmacists take calls late at night to walk through these choices with worried parents.
Any pregnant or breastfeeding woman considering treatment should check with her doctor or midwife. If treatment becomes necessary, keeping the clinic informed about her stage in pregnancy, health problems, and recent drug exposures gives her team the best shot at keeping both mother and child safe. Keeping communication open builds trust—something science supports and experience always proves right.
| Names | |
| Preferred IUPAC name | (methylsulfinyl)-1H-benzo[d]imidazol-2-ylcarbamate |
| Other names |
Albendazole S-oxide Ricobendazole Albendazolum sulfoxidum |
| Pronunciation | /ælˌbɛn.dəˈzoʊl sʌlˈfɒk.saɪd/ |
| Identifiers | |
| CAS Number | 54029-12-8 |
| 3D model (JSmol) | `3D model (JSmol)` string for **Albendazole Sulfoxide** is: ``` CN1C=NC2=C1N=C(S2)COC3=CC=CC=C3S(=O) ``` |
| Beilstein Reference | 146519 |
| ChEBI | CHEBI:85199 |
| ChEMBL | CHEMBL139360 |
| ChemSpider | 173337 |
| DrugBank | DB00518 |
| ECHA InfoCard | ECHA InfoCard: 100.045.850 |
| EC Number | EC 1.14.13.32 |
| Gmelin Reference | 1579245 |
| KEGG | C07416 |
| MeSH | D000489 |
| PubChem CID | 123619 |
| RTECS number | VA5950000 |
| UNII | R9671Y6Z2P |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C12H15N3O3S |
| Molar mass | 299.35 g/mol |
| Appearance | White to pale yellow crystalline powder |
| Odor | Odorless |
| Density | 1.37 g/cm3 |
| Solubility in water | Slightly soluble in water |
| log P | 1.93 |
| Vapor pressure | 2.69E-08 mmHg at 25°C |
| Acidity (pKa) | 4.38 |
| Basicity (pKb) | 2.39 |
| Magnetic susceptibility (χ) | -74.5×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.619 |
| Dipole moment | 3.68 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 362.06 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | Std enthalpy of combustion (ΔcH⦵298) of Albendazole Sulfoxide is -6720 kJ/mol |
| Pharmacology | |
| ATC code | P02CA03 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes eye irritation. May cause liver damage. |
| GHS labelling | GHS05, GHS07, GHS08 |
| Pictograms | GHS05, GHS07 |
| Signal word | Warning |
| Hazard statements | Harmful if swallowed. Causes serious eye irritation. May cause an allergic skin reaction. |
| Precautionary statements | P264, P270, P280, P302+P352, P305+P351+P338, P362+P364 |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | 70.9°C |
| Lethal dose or concentration | LD50 oral rat 2,400 mg/kg |
| LD50 (median dose) | 2620 mg/kg (Rat, oral) |
| NIOSH | PB8225000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 400 mg as a single dose |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Albendazole Albendazole sulfone Mebendazole Thiabendazole |
